Fibrinogen clinical trials
Also written Haemocomplettan P and EVARREST.
How each study uses Fibrinogen is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Fibrinogen studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 16 Jan 2009 · Riastap · BLA 125317 (FDA, Purple Book)
- European Union
- 8 Jun 2004 · TachoSil · EMEA/H/C/000505 (EMA; in a combination)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
62 studies that test it; most in 2014 (8)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 6 |
| 2011 | 6 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 8 |
| 2015 | 6 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 2 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 16 · Other 46
Ethicon, Inc. (7) · IRCCS Policlinico S. Donato (3) · CSL Behring (3) · Emory University (2) · Gold Coast Hospital and Health Service (2) · Mallinckrodt (2) · Sahlgrenska University Hospital (2) · Brno University Hospital (1)
Often tested with
Tested in the same studies.
Thrombin (10) · Cryoprecipitate (2) · Prothrombin complex concentrates (1) · Prothrombin complex concentrate (1)
Studies
Open first, then newest update. How each study uses Fibrinogen is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 62
- Pre-hospital Administration of Fibrinogen in Trauma-Induced CoagulopathyNot yet recruitingNot applicableUnidade Local de Saude do Arco RibeirinhoNCT06582420Written as Fibrinogen concentrate
- Factor In the Initial Resuscitation of Severe Trauma 2 PatientsTerminatedPhase 4University Health Network, TorontoNCT04534751Written as Fibrinogen + PCC
- Effect of Prophylactic Fibrinogen Concentrate In Scoliosis SurgeryCompletedPhase 4Brno University HospitalNCT05391412Written as Fibrinogen Concentrate Human
- Fibrinogen Early In Severe Trauma StudY IICompletedPhase 3Australian and New Zealand Intensive Care Research CentreNCT05449834Written as Fibrinogen Concentrate
- The EVARREST® Pediatric Mild or Moderate Liver and Soft Tissue Bleeding StudyCompletedPhase 3Ethicon, Inc.NCT03255174Written as EVARREST® Fibrin Sealant Patch
- Comparison of Fibrinogen Concentrate and Cryoprecipitate in Pediatric Cardiac Surgery PatientsCompletedPhase 4University of VirginiaNCT04376762Written as Fibrinogen
- Administration of Fibrinogen Concentrate for Refractory BleedingTerminatedPhase 2Centre Hospitalier Universitaire de Saint EtienneNCT05091684Written as Fibrinogen Concentrate Human
- Fibrinogen Replacement to Prevent Intracranial Haemorrhage in Ischemic Stroke Patients After Thrombolysis (FibER)CompletedPhase 3Azienda Usl di BolognaNCT05300672Written as fibrinogen infusion
- Fibrin Glue After ESD for High Risk Patients of BleedingCompletedNot applicableSeoul National University HospitalNCT04602689Written as Human fibrinogen concentrate
- Effectiveness of Different Fibrinogen Preparations in Restoring Clot FirmnessCompletedPhase 2IRCCS Policlinico S. DonatoNCT05780125Written as FibCLOT
- In Vivo Effects of Fibrinogen Concentrate (FC) Versus Cryoprecipitate on the Neonatal Fibrin Network Structure After Cardiopulmonary Bypass (CPB)CompletedPhase 3Emory UniversityNCT03932240Written as Fibrinogen Concentrate (FC)
- FIB Grifols Congenital Deficiency for On-demand Treatment and Surgical ProphylaxisWithdrawnPhase 3Instituto Grifols, S.A.NCT04636268Written as FIB Grifols
- The Paediatric EVICEL® Neuro StudyTerminatedPhase 3Ethicon, Inc.NCT02309645Written as EVICEL® Fibrin Sealant
- Fibrinogen Concentrate (Human) - Efficacy and Safety StudyWithdrawnPhase 3CSL BehringNCT00916656Written as Fibrinogen Concentrate, Human (FCH)
- ZEPLAST- PED: ZEro_PLASma Trial in Small Infants Undergoing Cardiac SurgeryTerminatedPhase 2IRCCS Policlinico S. DonatoNCT04434001Written as Fibrinogen Concentrate Human
- Human Fibrinogen Concentrate in Pediatric Cardiac SurgeryCompletedPhase 4Nicklaus Children's Hospital f/k/a Miami Children's HospitalNCT02822599Written as RiaStAP
- Patient Blood Management for Massive Obstetric HemorrhageCompletedNot applicableAngel Augusto Perez CalatayudNCT03784794Written as Fibrinogen Concentrate Human
- Platelets or Fibrinogen as First-line Treatment for Bleeding During Pedatric Heart SurgeryStatus unknownPhase 2Sahlgrenska University HospitalNCT04807621Written as Fibrinogen concentrate
- A Program to Evaluate Riastap® and FIBTEM® for the Early Control and Treatment of Postpartum Hemorrhage (PERFECT PPH)WithdrawnPhase 1/2Yale UniversityNCT02528708Written as fibrinogen concentrate
- Study to Assess the Efficacy, Safety and Pharmacokinetic of Octafibrin in Paediatric Subjects With Fibrinogen DeficiencyCompletedPhase 3OctapharmaNCT02408484Written as Octafibrin
See all 62 studies that test Fibrinogen →
As the comparator · 1 — what is tested is compared with Fibrinogen
What changed recently
From the registry's own updates since Oct 20, 2026.
Stopped1
- Factor In the Initial Resuscitation of Severe Trauma 2 PatientsTerminatedOct 21, 2026NCT04534751
Codes
What other systems call Fibrinogen · ClinicalTrials.gg INT007488
- UNII (FDA) N94833051KFIBRINOGEN HUMANConfirmed FDA, Wikidata
- RxNorm 2264108One source FDA
- Wikidata Q22075876human fibrinogenConfirmed FDA, Wikidata
- NCI Thesaurus C81126Fibrinogen HumanConfirmed FDA, Wikidata
- DrugBank DB09222One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | N94833051K | FIBRINOGEN HUMAN | Confirmed FDA, Wikidata |
| RxNorm | 2264108 | — | One source FDA |
| Wikidata | Q22075876 | human fibrinogen | Confirmed FDA, Wikidata |
| NCI Thesaurus | C81126 | Fibrinogen Human | Confirmed FDA, Wikidata |
| DrugBank | DB09222 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.